ChristineEngMD

Medical Genetics • Houston, TX

Clinical Genetics, Clinical Molecular Genetics, Pediatric Medical Genetics

Professor, Molecular & Human Genetics, Baylor College of Medicine

Join to view full profile

Dr. Eng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eng's full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-822-4280

Fax+1 832-825-4294

Education & Training

Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1986 - 1989
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1983 - 1986
Tulane University School of MedicineClass of 1983

Certifications & Licensure

TX State Medical License 2001 - 2026
NY State Medical License 1986 - 2020
LA State Medical License 1983 - 1984
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Clinical Trials

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase Start of enrollment: 2004 Sep 13
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

307 citations
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management
Linyan Meng, Mohan Pammi, Anirudh Saronwala, Pilar L. Magoulas, Andrew R. Ghazi
JAMA Pediatrics. 2017-12-04
360 citations
Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry
William R. Wilcox, João Paulo Oliveira, Robert J. Hopkin, Alberto Ortiz, Maryam Banikazemi
Molecular Genetics and Metabolism. 2008-02-01
356 citations
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer
Molecular Genetics and Metabolism. 2018-04-01

Journal Articles

Publisher Correction: Non-Invasive Prenatal Sequencing for Multiple Mendelian Monogenic Disorders Using Circulating Cell-Free Fetal DNA
Yue Wang, Arthur Beaudet, Christine M Eng, Ronald J Wapner, Sheetal Parmar, Nature
Clinical Exome Sequencing for Fetuses with Ultrasound Abnormalities and a Suspected Mendelian Disorder
Christine Eng, MD, BioMed Central
Clinical Exome Sequencing Reveals Locus Heterogeneity and Phenotypic Variability of Cohesinopathies
Scott E Hickey, Leah Slattery, James R Lupski, Margaret P Adam, Olivia Wenger, Davut Pehlivan, Laura Martin, Farida Abid, Dorothy Grange, Jennifer E Posey, Alison A Be..., Nature

Press Mentions

Diagnostic Laboratory Joint Venture Expands RNA Sequencing at BaylorAugust 6th, 2024
Genetic Testing for Childhood Cancer Patients Can Identify Cause, Treatment PotentialJanuary 28th, 2016
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental DelaysSeptember 13th, 2023
Join now to see all

Grant Support

Clinical Trial: A Multicenter Open-Label Study Of Gene-Activated Human GlucocereNational Center For Research Resources2009
Clinical Trial: An Open-Label Extension Of Study Tkt024 Evaluating Long-Term SAFNational Center For Research Resources2008
Clinical Trial: A Randomized, Open-Label, Study To Assess The Safety And TolerabNational Center For Research Resources2008
Expanded Access Use Of Recombinant Human Acid Alpha-Glucosidase (RHGAA) (MyozNational Center For Research Resources2006–2007
An Open-Label Extension Of Study Tkt024 Evaluating Long-Term Safety And CliniNational Center For Research Resources2006–2007
Multi-Center, OPEN Label Study Of The Safety And Efficacy Of Fabrazyme In PTSNational Center For Research Resources2006
Iduronate-2-Sulfatase Enzyme Replacement Therapy In Patients With MPS IINational Center For Research Resources2005–2006
Study Of The Safety And Efficacy Of Fabrazyme In Fabry PatientsNational Center For Research Resources2005
Phase 2, Randomized, Open-Label, Dose Ranging, Multiple Dose Study Of Fabrazyme2National Center For Research Resources2004
Iduronate-2-Sulfatase Enzyme Replacement Therapy In MPSNational Center For Research Resources2004
Outcomes Of Genetic Testing Among Ashkenazi FamiliesNational Cancer Institute2001–2002
Safety &Efficacy Of Recombinant Alpha Galactosidase-ANational Center For Research Resources2000–2002
Recombinant Enzyme Therapy For Fabry'S DiseaseNational Center For Research Resources2000–2002
Enzyme Replacement Therapy For Fabry DiseaseNational Center For Research Resources1999
Genetic Testing In Ashkenazi Jewish PopulationNational Center For Research Resources1997